Annual CAPEX
$840.00 K
-$900.00 K-51.72%
31 December 2023
Summary:
CytomX Therapeutics annual capital expenditures is currently $840.00 thousand, with the most recent change of -$900.00 thousand (-51.72%) on 31 December 2023. During the last 3 years, it has fallen by -$769.00 thousand (-47.79%). CTMX annual CAPEX is now -77.82% below its all-time high of $3.79 million, reached on 31 December 2018.CTMX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$19.00 K
-$77.00 K-80.21%
30 September 2024
Summary:
CytomX Therapeutics quarterly capital expenditures is currently $19.00 thousand, with the most recent change of -$77.00 thousand (-80.21%) on 30 September 2024. Over the past year, it has dropped by -$247.00 thousand (-92.86%). CTMX quarterly CAPEX is now -98.96% below its all-time high of $1.83 million, reached on 31 March 2019.CTMX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$496.00 K
+$10.00 K+2.06%
30 September 2024
Summary:
CytomX Therapeutics TTM capital expenditures is currently $496.00 thousand, with the most recent change of +$10.00 thousand (+2.06%) on 30 September 2024. Over the past year, it has dropped by -$344.00 thousand (-40.95%). CTMX TTM CAPEX is now -89.82% below its all-time high of $4.87 million, reached on 31 March 2019.CTMX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTMX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -92.9% | -41.0% |
| 3 y3 years | -47.8% | -92.2% | -69.2% |
| 5 y5 years | -76.0% | -97.3% | -85.8% |
CTMX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -51.7% | at low | -97.4% | +111.1% | -72.5% | +2.1% |
| 5 y | 5 years | -76.0% | at low | -98.2% | +111.1% | -85.8% | +2.1% |
| alltime | all time | -77.8% | +14.8% | -99.0% | +111.1% | -89.8% | +94.5% |
CytomX Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $19.00 K(-80.2%) | $496.00 K(+2.1%) |
| June 2024 | - | $96.00 K(-16.5%) | $486.00 K(-46.4%) |
| Mar 2024 | - | $115.00 K(-56.8%) | $907.00 K(+8.0%) |
| Dec 2023 | $840.00 K(-51.7%) | $266.00 K(+2855.6%) | $840.00 K(+11.1%) |
| Sept 2023 | - | $9000.00(-98.3%) | $756.00 K(-34.7%) |
| June 2023 | - | $517.00 K(+977.1%) | $1.16 M(+10.0%) |
| Mar 2023 | - | $48.00 K(-73.6%) | $1.05 M(-39.5%) |
| Dec 2022 | $1.74 M(+8.1%) | $182.00 K(-55.6%) | $1.74 M(-3.5%) |
| Sept 2022 | - | $410.00 K(-0.5%) | $1.80 M(+8.5%) |
| June 2022 | - | $412.00 K(-44.0%) | $1.66 M(+21.9%) |
| Mar 2022 | - | $736.00 K(+200.4%) | $1.36 M(-15.3%) |
| Dec 2021 | $1.61 M(-30.3%) | $245.00 K(-8.6%) | $1.61 M(-11.1%) |
| Sept 2021 | - | $268.00 K(+135.1%) | $1.81 M(-22.0%) |
| June 2021 | - | $114.00 K(-88.4%) | $2.32 M(+3.4%) |
| Mar 2021 | - | $982.00 K(+120.7%) | $2.24 M(-2.9%) |
| Dec 2020 | $2.31 M(-34.0%) | $445.00 K(-42.8%) | $2.31 M(-10.1%) |
| Sept 2020 | - | $778.00 K(+2002.7%) | $2.57 M(+6.2%) |
| June 2020 | - | $37.00 K(-96.5%) | $2.42 M(-10.8%) |
| Mar 2020 | - | $1.05 M(+49.2%) | $2.71 M(-22.5%) |
| Dec 2019 | $3.50 M | $703.00 K(+11.9%) | $3.50 M(-10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $628.00 K(+89.7%) | $3.91 M(-9.7%) |
| June 2019 | - | $331.00 K(-82.0%) | $4.33 M(-11.0%) |
| Mar 2019 | - | $1.83 M(+64.0%) | $4.87 M(+28.6%) |
| Dec 2018 | $3.79 M(+143.0%) | $1.12 M(+6.6%) | $3.79 M(+30.5%) |
| Sept 2018 | - | $1.05 M(+21.0%) | $2.90 M(+52.0%) |
| June 2018 | - | $868.00 K(+15.6%) | $1.91 M(+39.8%) |
| Mar 2018 | - | $751.00 K(+220.9%) | $1.37 M(-12.4%) |
| Dec 2017 | $1.56 M(-28.4%) | $234.00 K(+310.5%) | $1.56 M(-19.1%) |
| Sept 2017 | - | $57.00 K(-82.4%) | $1.93 M(-29.5%) |
| June 2017 | - | $324.00 K(-65.7%) | $2.73 M(-2.1%) |
| Mar 2017 | - | $944.00 K(+56.8%) | $2.79 M(+28.4%) |
| Dec 2016 | $2.18 M(+36.5%) | $602.00 K(-30.2%) | $2.18 M(+23.9%) |
| Sept 2016 | - | $863.00 K(+124.7%) | $1.76 M(+39.8%) |
| June 2016 | - | $384.00 K(+17.4%) | $1.26 M(-24.6%) |
| Mar 2016 | - | $327.00 K(+79.7%) | $1.67 M(+4.5%) |
| Dec 2015 | $1.59 M(-4.1%) | $182.00 K(-49.9%) | $1.59 M(+12.9%) |
| Sept 2015 | - | $363.00 K(-54.3%) | $1.41 M(+34.6%) |
| June 2015 | - | $794.00 K(+211.4%) | $1.05 M(+311.4%) |
| Mar 2015 | - | $255.00 K | $255.00 K |
| Dec 2014 | $1.66 M(+127.2%) | - | - |
| Dec 2013 | $732.00 K | - | - |
FAQ
- What is CytomX Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly CAPEX year-on-year change?
- What is CytomX Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for CytomX Therapeutics?
- What is CytomX Therapeutics TTM CAPEX year-on-year change?
What is CytomX Therapeutics annual capital expenditures?
The current annual CAPEX of CTMX is $840.00 K
What is the all time high annual CAPEX for CytomX Therapeutics?
CytomX Therapeutics all-time high annual capital expenditures is $3.79 M
What is CytomX Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of CTMX is $19.00 K
What is the all time high quarterly CAPEX for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly capital expenditures is $1.83 M
What is CytomX Therapeutics quarterly CAPEX year-on-year change?
Over the past year, CTMX quarterly capital expenditures has changed by -$247.00 K (-92.86%)
What is CytomX Therapeutics TTM capital expenditures?
The current TTM CAPEX of CTMX is $496.00 K
What is the all time high TTM CAPEX for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM capital expenditures is $4.87 M
What is CytomX Therapeutics TTM CAPEX year-on-year change?
Over the past year, CTMX TTM capital expenditures has changed by -$344.00 K (-40.95%)